Journal Information

Full Title: Postepy Dermatol Alergol

Abbreviation: Postepy Dermatol Alergol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Dermatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest Joanna Narbutt has worked as a Consultant or Speaker for AbbVie, Bioderma, Eli Lilly, Janssen, Leo Pharma, Medac, Novartis, Pierre-Fabre, and participated as Principal Investigator or Subinvestigator in clinical trials sponsored by AbbVie, UCB, Galderma, Janssen, Leo Pharma, Pfizer. Aleksandra Lesiak has worked as a Consultant or Speaker for AbbVie, Bioderma, Eli Lilly, Janssen, Leo Pharma, Medac, Novartis, Pierre-Fabre, and participated as a Principal Investigator or Subinvestigator in clinical trials sponsored by AbbVie, UCB, Galderma, Janssen, Leo Pharma, Pfizer. Małgorzata Skibińska has worked as a Consultant or Speaker for AbbVie, Eli Lilly, Janssen, Leo Pharma, Novartis, Pierre-Fabre. Sebastian Skoczylas, Tomasz Płoszaj, Dorota Sobolewska-Sztychny, Izabela Dróżdż and Karolina Brzychcy declare no conflict of interest."

Evidence found in paper:

"This research was funded by grant No. POWR.03.05.00-00-z065/17 statutory activities of the Medical University of Lodz no. 503/5-064-04/503-01."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025